San Francisco-based UCSF Health has named a new executive to monitor how AI is being used by clinicians.
Jinoos Yazdany, MD, was appointed March 19 as the inaugural executive director of AI monitoring in clinical care. She will oversee the Impact Monitoring Platform for Clinical Care, a collaboration between the health system and UCSF School of Medicine’s Division of Clinical Informatics and Digital Transformation.
“As AI becomes more deeply embedded in healthcare, we must take an active approach to monitoring,” she said in a news release. “IMPACC will be essential to ensuring these technologies are not only safe but also fair and truly beneficial for both patients and our health system.”
Dr. Yazdany serves as chief of rheumatology at Zuckerberg San Francisco General Hospital and the UCSF Alice Betts Endowed Professor of Medicine. She will work closely with UCSF Chief Health AI Officer Sara Murray, MD; DoC-IT Chief Julia Adler-Milstein, PhD; and Director of Data Science and AI Hossein Soleimani, PhD.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
